Compumed Stock Market Value
| CMPD Stock | USD 4.23 0.04 0.94% |
| Symbol | CompuMed |
CompuMed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CompuMed's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CompuMed.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in CompuMed on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding CompuMed or generate 0.0% return on investment in CompuMed over 90 days. CompuMed is related to or competes with Healthlynked Corp, Mosaic Immunoengineerin, and Vycor Medical. CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical f... More
CompuMed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CompuMed's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CompuMed upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.41 | |||
| Information Ratio | 0.1065 | |||
| Maximum Drawdown | 34.52 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 9.84 |
CompuMed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CompuMed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CompuMed's standard deviation. In reality, there are many statistical measures that can use CompuMed historical prices to predict the future CompuMed's volatility.| Risk Adjusted Performance | 0.108 | |||
| Jensen Alpha | 0.8355 | |||
| Total Risk Alpha | 0.0682 | |||
| Sortino Ratio | 0.1109 | |||
| Treynor Ratio | (0.41) |
CompuMed February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.108 | |||
| Market Risk Adjusted Performance | (0.40) | |||
| Mean Deviation | 3.87 | |||
| Semi Deviation | 3.64 | |||
| Downside Deviation | 5.41 | |||
| Coefficient Of Variation | 806.33 | |||
| Standard Deviation | 5.63 | |||
| Variance | 31.67 | |||
| Information Ratio | 0.1065 | |||
| Jensen Alpha | 0.8355 | |||
| Total Risk Alpha | 0.0682 | |||
| Sortino Ratio | 0.1109 | |||
| Treynor Ratio | (0.41) | |||
| Maximum Drawdown | 34.52 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 9.84 | |||
| Downside Variance | 29.24 | |||
| Semi Variance | 13.25 | |||
| Expected Short fall | (6.24) | |||
| Skewness | 0.9994 | |||
| Kurtosis | 2.76 |
CompuMed Backtested Returns
CompuMed appears to be risky, given 3 months investment horizon. CompuMed secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. By analyzing CompuMed's technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of CompuMed's Risk Adjusted Performance of 0.108, mean deviation of 3.87, and Downside Deviation of 5.41 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CompuMed holds a performance score of 8. The firm shows a Beta (market volatility) of -1.67, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CompuMed are expected to decrease by larger amounts. On the other hand, during market turmoil, CompuMed is expected to outperform it. Please check CompuMed's value at risk, and the relationship between the total risk alpha and expected short fall , to make a quick decision on whether CompuMed's price patterns will revert.
Auto-correlation | -0.21 |
Weak reverse predictability
CompuMed has weak reverse predictability. Overlapping area represents the amount of predictability between CompuMed time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CompuMed price movement. The serial correlation of -0.21 indicates that over 21.0% of current CompuMed price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CompuMed Pink Sheet
CompuMed financial ratios help investors to determine whether CompuMed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CompuMed with respect to the benefits of owning CompuMed security.